Tal Zvi Zaks
CIK 1690927 · Chief Medical Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.81M
Companies
4
Total Filings
91
Lifetime Open-Market Net
-$124.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEVA | Director | 73,264 | $34.57 | $2.53M | $0 | 10 | 2026-06-08 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 3 | 2022-07-01 |
| MRNA | Chief Medical Officer | 5,000 | $54.94 | $274.7K | -$124.16M | 74 | 2021-07-02 |
| ASND | Director | — | $253.69 | — | $0 | 4 | 2019-07-03 |
Recent Filings · Page 2 of 10
91 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-08 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | MRNA | Mixed | — | -$1.06M | EDGAR |
| 2021-07-02 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-25 | MRNA | Mixed | — | -$968.6K | EDGAR |
| 2021-06-21 | MRNA | Mixed | — | -$870.4K | EDGAR |
| 2021-06-11 | MRNA | Mixed | — | -$931.9K | EDGAR |
| 2021-06-03 | MRNA | Mixed | — | -$789.9K | EDGAR |
| 2021-05-27 | MRNA | Mixed | — | -$713.9K | EDGAR |
| 2021-05-20 | MRNA | Mixed | — | -$649.0K | EDGAR |
| 2021-05-13 | MRNA | Mixed | — | -$640.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.